Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Bevacizumab + Tax In Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2